Tech Company Financing Transactions

Epsilogen Funding Round

Epsilogen, based in London, secured $16 million from 3B Future Health Fund, British Patient Capital and Epidarex Capital.

Transaction Overview

Company Name
Announced On
9/9/2024
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to expand operations ann its R&D sector.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
London BioScience Innovation Centre 2 Royal College St.
London, NW1 0NH
UK
Email Address
Overview
Epsilogen is a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life.
Profile
Epsilogen LinkedIn Company Profile
Social Media
Epsilogen Company Twitter Account
Company News
Epsilogen News
Facebook
Epsilogen on Facebook
YouTube
Epsilogen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Timothy Wilson
  Timothy Wilson LinkedIn Profile  Timothy Wilson Twitter Account  Timothy Wilson News  Timothy Wilson on Facebook
Chief Financial Officer
Ian Ardill
  Ian Ardill LinkedIn Profile  Ian Ardill Twitter Account  Ian Ardill News  Ian Ardill on Facebook
Chief Scientific Officer
Kevin FitzGerald
  Kevin FitzGerald LinkedIn Profile  Kevin FitzGerald Twitter Account  Kevin FitzGerald News  Kevin FitzGerald on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/9/2024: Superluminal Medicines venture capital transaction
Next: 9/10/2024: StackGen venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary